β-Fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort

American Journal of Kidney Diseases

Volumn 46, Issue 1, 2005, Pages 78-85

  Liu, Yongmei ^a   Berthier Schaad, Yvette ^b   Fink, Nancy E ^b   Fallin, Margaret D ^b   Tracy, Russell P ^b   Klag, Michael J ^b   Smith, Michael W ^b   Coresh, Josef ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Fibrinogen (FGB) gene; Cardiovascular disease (CVD); Cohort studies; End stage renal disease (ESRD); Haplotypes; Inflammation

Indexed keywords

FIBRINOGEN;

ADULT; AGE DISTRIBUTION; ALLELE; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEMODIALYSIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; SEX RATIO; SMOKING;

ADULT; AGED; ALLELES; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL DIALYSIS; RISK; SMOKING;

EID: 20544464393     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.03.008     Document Type: Article

References (47)

1. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, C. Wanner Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney Int 55 1999 648 658
2. C. Wanner, J. Zimmermann, T. Quaschning, J. Galle Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients Kidney Int Suppl 62 1997 S53 S55
3. I. Behague, O. Poirier, V. Nicaud Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde Circulation 93 1996 440 449
4. P. Jungers, Z.A. Massy, T.N. Khoa Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients A prospective study Nephrol Dial Transplant 12 1997 2597 2602
5. C. Zoccali, F.A. Benedetto, F. Mallamaci Creed Investigators Inflammation is associated with carotid atherosclerosis in dialysis patients. Cardiovascular Risk Extended Evaluation in Dialysis Patients J Hypertens 18 2000 1207 1213
6. M. Boaz, Z. Matas, A. Biro Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients Am J Kidney Dis 34 1999 438 444
7. A. Irish Cardiovascular disease, fibrinogen and the acute phase response Associations with lipids and blood pressure in patients with chronic renal disease Atherosclerosis 137 1998 133 139
8. M. de Lange, H. Snieder, R.A. Ariens, T.D. Spector, P.J. Grant The genetics of haemostasis A twin study Lancet 357 2001 101 105
9. F.M. 't Hooft, S.J. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, A. Hamsten Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration Arterioscler Thromb Vasc Biol 19 1999 3063 3070
10. A.R. Folsom, K.K. Wu, M. Rasmussen, L.E. Chambless, N. Aleksic, F.J. Nieto Determinants of population changes in fibrinogen and factor VII over 6 years The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol 20 2000 601 606
11. K.S. Lam, O.C. Ma, N.M. Wat, L.C. Chan, E.D. Janus Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes Diabetologia 42 1999 1250 1253
12. F. Green, A. Hamsten, M. Blomback, S. Humphries The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden Thromb Haemost 70 1993 915 920
13. S.E. Humphries, L.A. Luong, H.E. Montgomery, I.N. Day, V. Mohamed-Ali, J.S. Yudkin Gene-environment interaction in the determination of levels of plasma fibrinogen Thromb Haemost 82 1999 818 825
14. S.E. Humphries, S. Ye, P. Talmud, L. Bara, L. Wilhelmsen, L. Tiret European Atherosclerosis Research Study Genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction Arterioscler Thromb Vasc Biol 15 1995 96 104
15. C. Kessler, C. Spitzer, D. Stauske The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease Arterioscler Thromb Vasc Biol 17 1997 2880 2884
16. M.P. de Maat, J.J. Kastelein, J.W. Jukema REGRESS Group -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men Proposed role for an acute-phase reaction pattern of fibrinogen Arterioscler Thromb Vasc Biol 18 1998 265 271
17. H. Schmidt, R. Schmidt, K. Niederkorn Beta-fibrinogen gene polymorphism (C148→T) is associated with carotid atherosclerosis Results of the Austrian Stroke Prevention Study Arterioscler Thromb Vasc Biol 18 1998 487 492
18. S. Nishiuma, K. Kario, K. Yakushijin Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population Blood Coagul Fibrinolysis 9 1998 373 379
19. A.J. Lee, F.G. Fowkes, G.D. Lowe, J.M. Connor, A. Rumley Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis Edinburgh Artery Study Thromb Haemost 81 1999 553 560
20. A. Gardemann, O. Schwartz, W. Haberbosch Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction Thromb Haemost 77 1997 1120 1126
21. S.M. Boekholdt, N.R. Bijsterveld, A.H. Moons, M. Levi, H.R. Buller, R.J. Peters Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction A systematic review Circulation 104 2001 3063 3068
22. C.J. Doggen, R.M. Bertina, V.M. Cats, F.R. Rosendaal Fibrinogen polymorphisms are not associated with the risk of myocardial infarction Br J Haematol 110 2000 935 938
23. P.Y. Scarabin, L. Bara, S. Ricard Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study Arterioscler Thromb 13 1993 886 891
24. A. Tybjaerg-Hansen, B. Agerholm-Larsen, S.E. Humphries, S. Abildgaard, P. Schnohr, B.G. Nordestgaard A common mutation (G-455→A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study J Clin Invest 99 1997 3034 3039
25. K. Lewandowski, P. Kwasnikowski, W. Elikowski, K. Zawilska Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen Kardiol Pol 59 2003 205 212
26. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age Circulation 107 2003 1117 1122
27. M. Martiskainen, T. Pohjasvaara, J. Mikkelsson Fibrinogen gene promoter -455A allele as a risk factor for lacunar stroke Stroke 34 2003 886 891
28. F.R. Green Fibrinogen polymorphisms and atherothrombotic disease Ann N Y Acad Sci 936 2001 549 559
29. C. Wanner, J. Zimmermann, T. Quaschning, J. Galle Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients Kidney Int Suppl 62 1997 S53 S55
30. J.C. Longenecker, J. Coresh, N.R. Powe Traditional cardiovascular disease risk factors in dialysis patients compared with the general population The CHOICE Study J Am Soc Nephrol 13 2002 1918 1927
31. M.V. Rocco, G. Yan, J. Gassman Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis Health Care Financing Administration Am J Kidney Dis 39 2002 146 153
32. C.S. Carlson, M.A. Eberle, M.J. Rieder, J.D. Smith, L. Kruglyak, D.A. Nickerson Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans Nat Genet 33 2003 518 521
33. A.P. Fellowes, S.O. Brennan, P.M. George Identification and characterization of five new fibrinogen gene polymorphisms Ann N Y Acad Sci 936 2001 536 541
34. K. Lindblad-Toh, E. Winchester, M.J. Daly Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse Nat Genet 24 2000 381 386
35. R.P. Tracy, R.N. Lemaitre, B.M. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
36. M. Stephens, N.J. Smith, P. Donnelly A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 2001 978 989
37. US Renal Data System USRDS 1999 Annual Data Report 1999 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
38. B. Devlin, N. Risch A comparison of linkage disequilibrium measures for fine-scale mapping Genomics 29 1995 311 322
39. A.R. Folsom, N. Aleksic, C. Ahn, E. Boerwinkle, K.K. Wu Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence The Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 11 2001 166 170
40. S.G. Thompson, J.C. Martin, T.W. Meade Sources of variability in coagulation factor assays Thromb Haemost 58 1987 1073 1077
41. L.E. Chambless, R. McMahon, K. Wu, A. Folsom, A. Finch, Y.L. Shen Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study Ann Epidemiol 2 1992 723 733
42. G.J. Blake, C. Schmitz, K. Lindpaintner, P.M. Ridker Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis Eur Heart J 22 2001 2262 2266
43. J. Dalmon, M. Laurent, G. Courtois The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element Mol Cell Biol 13 1993 1183 1193
44. G.M. Anderson, A.R. Shaw, J.A. Shafer Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins J Biol Chem 268 1993 22650 22655
45. P.A. Metcalf, A.R. Folsom, C.E. Davis, K.K. Wu, G. Heiss Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus Diabetes Res Clin Pract 47 2000 25 35
46. S.E. Humphries, A. Panahloo, H.E. Montgomery, F. Green, J. Yudkin Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis Thromb Haemost 78 1997 457 461
47. T.W. Meade, J. Imeson, Y. Stirling Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease Lancet 2 1987 986 988